Lode Debrabandere
Overview
Lode Debrabandere received an average of $557K in total compensation, including $261K in salary, at Osiris Therapeutics from 2006 to 2014.
2014Osiris TherapeuticsPresident and CEO
2013Osiris TherapeuticsPresident and CEO
2012Osiris TherapeuticsPresident and CEO
2011Osiris TherapeuticsPresident and CEO
2010Osiris TherapeuticsSenior Vice President,
2009Osiris TherapeuticsSenior Vice President,
2008Osiris TherapeuticsSenior Vice President,
2007Osiris TherapeuticsSenior Vice President,
2006Osiris TherapeuticsVice President and General Manager, Inflammatory Diseases
Source: SEC filings on April 30, 2015, March 28, 2014, April 27, 2012, April 14, 2011, April 16, 2010, and April 30, 2007.
Related executives
We found 18 more executives who work or worked at Osiris Therapeutics.
Alla Danilkovitch
Osiris Therapeutics
Chief Scientific Officer
Jason Keefer
Osiris Therapeutics
Chief Executive Officer
Linda Palczuk
Osiris Therapeutics
Chief Executive Officer
Linda Chang
Osiris Therapeutics
Chief Financial Officer
David Dresner
Osiris Therapeutics
Chief Executive Officer
Gregory Law
Osiris Therapeutics
Chief Financial Officer
R Avendano
Osiris Therapeutics
Chief Medical Officer
Frank Czworka
Osiris Therapeutics